Whole exome sequencing identified two homozygous ALMS1 mutations in an Iranian family with Alström syndrome.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
15 Feb 2020
Historique:
received: 23 07 2019
revised: 22 10 2019
accepted: 23 10 2019
pubmed: 2 11 2019
medline: 19 2 2020
entrez: 1 11 2019
Statut: ppublish

Résumé

Alström syndrome (AS) is a rare monogenic multi-system ciliopathy disorder with cardinal features, including cone-rod dystrophy, sensory neural hearing loss, metabolic dysfunctions and multiple organ failure caused by bi-allelic mutations in a centrosomal basal body protein-coding gene known as ALMS1. This study aimed to identify pathogenic mutations in a consanguineous Iranian family with AS. Next-generation sequencing was performed on the genomic DNA obtained from a 12 years old girl with AS. According to the bioinformatics analysis, computational modelling and segregation of variants, we identified two homozygous mutations close together in exon 8 of ALMS1 in the patient, including c.7262 G > T and c.7303-7305delAG. The clinically normal parents were heterozygous for both mutations. These mutations have a very rare frequency and only reported in the heterozygous state in the public genomic databases. Overall, due to the large size of the ALMS1 gene and clinical similarity with other ciliopathies and genetic disorders, whole exome sequencing can be useful for the identification of pathogenic mutations and the improvement of AS clinical management.

Identifiants

pubmed: 31669637
pii: S0378-1119(19)30887-X
doi: 10.1016/j.gene.2019.144228
pii:
doi:

Substances chimiques

ALMS1 protein, human 0
Cell Cycle Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144228

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Shahram Torkamandi (S)

Department of Medical Genetics and Immunology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Somaye Rezaei (S)

Department of Neurology, Imam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran.

Reza Mirfakhraei (R)

Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Masomeh Askari (M)

Department of Genetics at Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Samira Piltan (S)

Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Milad Gholami (M)

Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran. Electronic address: mtu.q220@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH